Cloning, expression and renaturation studies of reteplase

Journal of Microbiology and Biotechnology

Volumn 13, Issue 6, 2003, Pages 989-992

  Zhao, Youchun ^a   Ge, Wang ^a,b   Kong, Yang ^a   Zhang, Changkai ^a  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Younglong Biotechnology Co   (China)

Author keywords

Cloning and expression; Protein disulfide isomerasse; Renaturation; Reteplase

Indexed keywords

AGAROSE; AMINO ACID; COMPLEMENTARY DNA; FIBRINOLYTIC AGENT; LYSINE; PROTEIN DISULFIDE ISOMERASE; RETEPLASE; SEPHAROSE;

AFFINITY CHROMATOGRAPHY; AMINO ACID COMPOSITION; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; CELL INCLUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG COST; DRUG HALF LIFE; DRUG POTENCY; DRUG PURIFICATION; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC RECOMBINATION; ION EXCHANGE CHROMATOGRAPHY; MOLECULAR CLONING; MOUSE; NONHUMAN; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN RENATURATION; THROMBUS; WESTERN BLOTTING;

ANIMALIA; ESCHERICHIA COLI;

EID: 0347989257     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Albrecht, S., T. Luther, H. Grossman, C. Flossel, M. Kotzsch, and M. Muller. 1992. An ELISA for tissue factor using monoclonal antibodies. Blood Coagul. Fibrinolysis 3: 263-270.
2. Bode, C., R. W. Smalling, G. Berg, C. Burnett, G. Lorch, J. M. Kalbfleisch, R. Chernoff, L. G. Christie, R. L. Feldman, A. A. Seals, and W. D. Weaver. 1996. Randomized comparison of coronary thrombolysis achieved with double-bolus reteolase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigation. Circulation 94: 891-898.
3. Collen, D., H. R. Lijnen, P. A. Todd, and K. L. Goa. 1989. Tissue-type plasminogen activator: A review of its pharmacology and therapeutic use as a thrombolytic agent. Drugs 38: 346-388.
4. Creighton, T. E., D. A. Hillson, and R. B. Freedman. 1980. Catalysis by protein-disulphide isomerase of the unfolding and refolding of proteins with disulphide bonds. J. Mol. Biol. 142: 43-62.
5. Wang, G., Y. Zhao, Y. Kong, W. Wang, B. Li, F. Xue, and C. Zhang. 2001. A novel engineering clot buster-Reteplase, papers pp. 73-74. In Chinese Academy of Engineering, Symposium on Frontiers of Biotechnology and Pharmaceuticals, August, Weihai.
6. Gilbert, H. F. 1994. Catalysis of protein folding by agarose-immobilized protein disufide isomerase. Protein Express. Purif 2: 194-198.
7. Hawkins, H. C. and R. B. Freedman. 1991. The reactivities and ionization properties of the active-site dithiol groups of mammalian protein disulfide-isomerase. Biochem. J. 275: 335-339.
8. Kohnert, U., R. Rudolph, J. H. Verheijen, E. J. Weening Verhoeff, A. Stem, U. Opitz, U. Martin, H. Lill, H. Prinz, and M. Lechner. 1992. Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022. Protein Eng. 5: 93-97.
9. Martin, U., G. Sponer, and K. Strein. 1992. Evaluation of thrombolytic and systemic effects of the novel recombinatnt plasminogen activator BM06.022 compared with alteplase, anistreplase, streptokinase in a canine model of coronary artery thrombosis. J. Am. Coll. Cardiol. 19: 433-440.
10. Martin, U., R. Bader, Y. Bohm, Y. Kohner, V. Mollendorf, S. Fisher, and G. Sponer. 1993. BM06.022: A novel recombinant plasminongen activator. Cardiovasc. Drug Rev. 1: 299-311.
11. Neuhaus, K. L., R. von Essen, A. Vogt, V. Atebbe, J. Rustige, H. J. Wagner, K. F. Appel, U. Stienen, R. Konig, and W. Meger-Sabelek. 1994. Does finding with a novel recombinant plasminogen activator (BM06.022) in patients with acute myocardial infarction: Results of the German Recombinant Plasminogen Activator Study. J. Am. Coll. Cardiol. 24: 55-60.
12. Noble, S. and D. McTavish. 1996. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction. Drugs 52: 589-605.
13. Noiva, R. and W. J. Lennarz. 1992. Protein disulfide isomerase. A multifunctional protein resident in the lumen of the endoplasmic reticulum. J. Biol. Chem. 267: 3553-3556.
14. Rijken, D. C., E. Groeneveld, and M. M. Barrett-Bergshoeff. 1994. In vitro stability of a tissue-type plasminogen activator mutant, BM06.022, in human plasma. Thromb. Haemost. 72: 906-911.
15. Seifried, E., M. M. Muller, U. Martin, R. Konig, and V. Hombach. 1992. Bolus application of a novel recombinant plasminogen activator in acute myocardial infarction patients: Pharmacokinetics and effects on the hemostatic system. Ann. N. Y. Acad. Sci. 4: 417-420.
16. Smalling, R. W. 1997. A fresh look at the molecullaur pharmacology of plasminogen activators: From theory to test tube to clinical outcomes. Am. J. Health Syst. Pharm. 54: S17-S22.
17. Stringer, K. A. 1996. Tutorial biochemical and pharmacologic comparison of thrombolytic agents. Pharmacotherapy 16: 119-126.
18. Tang, B., S. Zhang, and K. Yang. 1994. Assisted refolding of recombinant prochymosin with the aid of protein disulphide isomerase. Biochem. J. 301: 17-20.
19. Verheijen, J. H., E. Mullart, G. T. Chang, C. Klu, and G. Wijngaards. 1982. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb. Haemost. 48: 266-269.
20. Wagstaff, A. J., J. C. Gillis, and K. L. A. Goa. 1995. A reappraisal of its pharmacology and therapeutic use in vascular disorders other than acute myocardial infarction. Drug Evaluation 50: 289-316.
21. Zhao, Y., G. Wang, and C. Zhang. 2003. Confirm of biochemical properties of reteplase. Sci. Technol. Chem. Ind. 11: 71-73.